Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research.

Lämmle, Bernhard; Rossmann, Heidi

Lämmle, Bernhard; Rossmann, Heidi.

Lämmle B; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, CH 3010 Bern, Switzerland; Haemostasis Research Unit, University College London, London WC1E 6BT, UK. Electronic address: bernhard.laemmle@uni-mainz.de.
Rossmann H; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.

Thromb Res ; 204: 141-142, 2021 08.

Article in English | MEDLINE | ID: covidwho-1117715

Subject(s)

COVID-19; Thrombosis; ADAMTS13 Protein; Blood Coagulation Tests; Humans; SARS-CoV-2; von Willebrand Factor

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 Limits: Humans Language: English Journal: Thromb Res Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google